Parkinson's disease and age: The obvious but largely unexplored link

Experimental Gerontology

Volumn 68, Issue , 2015, Pages 33-38

  Abdullah, Rashed ^a   Basak, Indranil ^a   Patil, Ketan S ^a   Alves, Guido ^b   Larsen, Jan Petter ^b   Møller, Simon Geir ^a,b  

^a ST JOHN'S UNIVERSITY   (United States)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aging; Autophagy; Genetics; Oxidative stress; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; COPPER; DJ 1 PROTEIN; GUANOSINE TRIPHOSPHATASE; LEUCINE RICH REPEAT KINASE 2; PARAQUAT; REACTIVE OXYGEN METABOLITE; LRRK2 PROTEIN, HUMAN; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

AGE; AGING; ARTICLE; AUTOPHAGY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; LRRK2 GENE; MITOPHAGY; MUTATIONAL ANALYSIS; NERVE FUNCTION; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SNCA GENE; CELL DEATH; ENVIRONMENT; LATE ONSET DISORDER; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ALPHA-SYNUCLEIN; AUTOPHAGY; CELL DEATH; ENVIRONMENT; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LATE ONSET DISORDERS; MITOCHONDRIAL DEGRADATION; NEURONS; ONCOGENE PROTEINS; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES;

EID: 84940461152     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.09.014     Document Type: Article

References (80)

1. Alvarez-Erviti L., Seow Y., Schapira A.H., Rodriguez-Oroz M.C., Obeso J.A., Cooper J.M. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease. Cell Death Dis. 2013, 4:e545.
2. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T.M., Thomas B., Ko H.S., Sasaki M., Ischiropoulos H., Przedborski S., Dawson T.M., Dawson V.L. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. 2007, 104:14807-14812.
3. Appel-Cresswell S., Vilarino-Guell C., Yu I., Shah B., Weir D., Thompson C., Stoessl J.A., Farrer M.J. Alpha-synuclein H50Q, a novel pathogenic mutation for Parkinson's disease. Mov. Disord. 2012, 27(Suppl. 1):1360.
4. Ariga H., Takahashi-Niki K., Kato I., Maita H., Niki T., Iguchi-Ariga S.M. Neuroprotective function of DJ-1 in Parkinson's disease. Oxid. Med. Cell. Longev. 2013, 2013:683920.
5. Ballard P.A., Tetrud J.W., Langston J.W. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 1985, 35:949-956.
6. Biskup S., Moore D.J., Rea A., Lorenz-Deperieux B., Coombes C.E., Dawson V.L., Dawson T.M., West A.B. Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMC Neurosci. 2007, 8:102.
7. Björkblom B., Adilbayeva A., Maple-Grødem J., Piston D., Ökvist M., Xu X.M., Brede C., Larsen J.P., Møller S.G. Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity. J. Biol. Chem. 2013, 288:22809-22820.
8. Björkblom B., Maple-Grødem J., Puno M.R., Odell M., Larsen J.P., Møller S.G. Reactive oxygen species-mediated DJ-1 monomerization modulates intracellular trafficking involving karyopherin β2. Mol. Cell. Biol. 2014, 34:3024-3040.
9. Bosco D.A., Fowler D.M., Zhang Q., Nieva J., Powers E.T., Wentworth P., Lerner R.A., Kelly J.W. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat. Chem. Biol. 2006, 2:249-253.
10. Brown D.R. α-Synuclein as a ferrireductase. Biochem. Soc. Trans. 2013, 41:1513-1517.
11. Burbulla L.F., Krüger R. Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease. J. Neurol. Sci. 2011, 306:1-8.
12. Canet-Avilés R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., Cookson M.R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9103-9108.
13. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., Destée A. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004, 364:1167-1169.
14. Cherra S.J., Steer E., Gusdon A.M., Kiselyov K., Chu C.T. Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons. Am. J. Pathol. 2013, 182:474-484.
15. Cole N.B., Murphy D.D., Lebowitz J., Di Noto L., Levine R.L., Nussbaum R.L. Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. J. Biol. Chem. 2005, 280:9678-9690.
16. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., Allison D.B., Cruzen C., Simmons H.A., Kemnitz J.W., Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
17. Cookson M.R. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat. Rev. Neurosci. 2010, 11:791-797.
18. Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004, 305:1292-1295.
19. Davies K.M., Bohic S., Carmona A., Ortega R., Cottam V., Hare D.J., Finberg J.P., Reyes S., Halliday G.M., Mercer J.F., Double K.L. Copper pathology in vulnerable brain regions in Parkinson's disease. Neurobiol. Aging 2014, 35:858-866.
20. Deng H., Dodson M.W., Huang H., Guo M. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14503-14508.
21. Dexter D.T., Wells F.R., Lees A.J., Agid F., Agid Y., Jenner P., Marsden C.D. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 1989, 52:1830-1836.
22. Esteves A.R., Swerdlow R.H., Cardoso S.M. LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis. Exp. Neurol. 2014, 261:206-216.
23. Gasper R., Meyer S., Gotthardt K., Sirajuddin M., Wittinghofer A. It takes two to tango: regulation of G proteins by dimerization. Nat. Rev. Mol. Cell Biol. 2009, 10:423-429.
24. Gómez-Suaga P., Fdez E., Fernández B., Martínez-Salvador M., Blanca Ramírez M., Madero-Pérez J., Rivero-Ríos P., Fuentes J.M., Hilfiker S. Novel insights into the neurobiology underlying LRRK2-linked Parkinson's disease. Neuropharmacology 2014, 85:45-56.
25. Gorner K., Holtorf E., Odoy S., Nuscher B., Yamamoto A., Regula J.T., Beyer K., Haass C., Kahle P.J. Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1. J. Biol. Chem. 2004, 279:6943-6951.
26. Greggio E., Cookson M.R. Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro 2009, 1. (pii: e00002).
27. Guo L., Gandhi P.N., Wang W., Petersen R.B., Wilson-Delfosse A.L., Chen S.G. The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp. Cell Res. 2007, 313:3658-3670.
28. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
29. Harman D. The biologic clock: the mitochondria?. J. Am. Geriatr. Soc. 1972, 20:145-147.
30. Haugarvoll K., Wszolek Z.K. Clinical features of LRRK2 parkinsonism. Parkinsonism Relat. Disord. 2009, 3:S205-S208.
31. Hindle J. Ageing, neurodegeneration and Parkinson's disease. Age Ageing 2010, 39:156-161.
32. Irrcher I., Aleyasin H., Seifert E.L., Hewitt S.J., Chhabra S., Phillips M., Lutz A.K., Rousseaux M.W., Bevilacqua L., Jahani-Asl A., Callaghan S., MacLaurin J.G., Winklhofer K.F., Rizzu P., Rippstein P., Kim R.H., Chen C.X., Fon E.A., Slack R.S., Harper M.E., McBride H.M., Mak T.W., Park D.S. Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum. Mol. Genet. 2010, 19:3734-3746.
33. Jang H.H., Lee K.O., Chi Y.H., Jung B.G., Park S.K., Park J.H., Lee J.R., Lee S.S., Moon J.C., Yun J.W., Choi Y.O., Kim W.Y., Kang J.S., Cheong G.W., Yun D.J., Rhee S.G., Cho M.J., Lee S.Y. Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 2004, 117:625-635.
34. Junn E., Jang W.H., Zhao X., Jeong B.S., Mouradian M.M. Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J. Neurosci. Res. 2009, 87:123-129.
35. Kamel F., Tanner C., Umbach D., Hoppin J., Alavanja M., Blair A., Comyns K., Goldman S., Korell M., Langston J., Ross G., Sandler D. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am. J. Epidemiol. 2007, 165:364-374.
36. Kawamoto Y., Kobayashi Y., Suzuki Y., Inoue H., Tomimoto H., Akiguchi I., Budka H., Martins L.M., Downward J., Takahashi R. Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies. J. Neuropathol. Exp. Neurol. 2008, 67:984-993.
37. Kiffin R., Kaushik S., Zeng M., Bandyopadhyay U., Zhang C., Massey A.C., Martinez-Vicente M., Cuervo A.M. Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age. J. Cell Sci. 2007, 120:782-791.
38. Kim R.H., Peters M., Jang Y., Shi W., Pintilie M., Fletcher G.C., DeLuca C., Liepa J., Zhou L., Snow B., Binari R.C., Manoukian A.S., Bray M.R., Liu F.F., Tsao M.S., Mak T.W. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005, 7:263-273.
39. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
40. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 1998, 18:106-108.
41. Kumar A., Cookson M.R. Role of LRRK2 kinase dysfunction in Parkinson disease. Expert Rev. Mol. Med. 2011, 13:e20.
42. Lee B.D., Dawson V.L., Dawson T.M. Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease. Trends Pharmacol. Sci. 2012, 33:365-373.
43. Lesage S., Anheim M., Letournel F., Bousset L., Honoré A., Rozas N., Pieri L., Madiona K., Dürr A., Melki R., Verny C., Brice A., French Parkinson's Disease Genetics Study Group G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann. Neurol. 2013, 73:459-471.
44. Liang C.L., Wang T.T., Luby-Phelps K., German D.C. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease. Exp. Neurol. 2007, 203:370-380.
45. Maita C., Maita H., Iguchi-Ariga S.M., Ariga H. Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants. PLoS One 2013, 8:e54087.
46. Miotto M.C., Rodriguez E.E., Valiente-Gabioud A.A., Torres-Monserrat V., Binolfi A., Quintanar L., Zweckstetter M., Griesinger C., Fernández C.O. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease. Inorg. Chem. 2014, 53:4350-4358.
47. Montes S., Rivera-Mancia S., Diaz-Ruiz A., Tristan-Lopez L., Rios C. Copper and copper proteins in Parkinson's disease. Oxid. Med. Cell. Longev. 2014, 2014:147251.
48. Moon J.C., Hah Y.S., Kim W.Y., Jung B.G., Jang H.H., Lee J.R., Kim S.Y., Lee Y.M., Jeon M.G., Kim C.W., Cho M.J., Lee S.Y. Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death. J. Biol. Chem. 2005, 280:28775-28784.
49. Nagakubo D., Taira T., Kitaura H., Ikeda M., Tamai K., Iguchi-Ariga S.M., Ariga H. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun. 1997, 231:509-513.
50. Nakabeppu Y., Tsuchimoto D., Yamaguchi H., Sakumi K. Oxidative damage in nucleic acids and Parkinson's disease. J. Neurosci. Res. 2007, 85:919-934.
51. Neumann C.A., Krause D.S., Carman C.V., Das S., Dubey D.P., Abraham J.L., Bronson R.T., Fujiwara Y., Orkin S.H., Van Etten R.A. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 2003, 424:561-565.
52. Nyström T., Yang J., Molin M. Peroxiredoxins, gerontogenes linking aging to genome instability and cancer. Genes Dev. 2012, 26:2001-2008.
53. Obeso J.A., Rodriguez-Oroz M.C., Goetz C.G., Marin C., Kordower J.H., Rodriguez M., Hirsch E.C., Farrer M., Schapira A.H., Halliday G. Missing pieces in the Parkinson's disease puzzle. Nat. Med. 2010, 16:653-661.
54. Orenstein S.J., Kuo S.H., Tasset I., Arias E., Koga H., Fernandez-Carasa I., Cortes E., Honig L.S., Dauer W., Consiglio A., Raya A., Sulzer D., Cuervo A.M. Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 2013, 16:394-406.
55. Patil K.S., Basak I., Lee S., Abdullah R., Larsen J.P., Møller S.G. PARK13 regulates PINK1 and subcellular relocation patterns under oxidative stress in neurons. J. Neurosci. Res. 2014, 92:1167-1177.
56. Pezzoli G., Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology 2013, 80:2035-2041.
57. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
58. Poole A.C., Thomas R.E., Andrews L.A., McBride H.M., Whitworth A.J., Pallanck L.J. The PINK1/parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1638-1643.
59. Proukakis C., Houlden H., Schapira A.H. Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data. Mov. Disord. 2013, 28:705-712.
60. Puno M.R., Patel N.A., Møller S.G., Robinson C.V., Moody P.C., Odell M. Structure of Cu(I)-bound DJ-1 reveals a biscysteinate metal binding site at the homodimer interface: insights into mutational inactivation of DJ-1 in Parkinsonism. J. Am. Chem. Soc. 2013, 135:15974-15977.
61. Ramsey C.P., Giasson B.I. The E163K DJ-1 mutant shows specific antioxidant deficiency. Brain Res. 2008, 1239:1-11.
62. Reeve A., Simcox E., Turnbull D. Ageing and Parkinson's disease: why is advancing age the biggest risk factor?. Ageing Res. Rev. 2014, 14:19-30.
63. Saez I., Vilchez D. The mechanistic links between proteasome activity, aging and age-related diseases. Curr. Genomics 2014, 15:38-51.
64. Santini E., Heiman M., Greengard P., Valjent E., Fisone G. Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. Sci. Signal. 2009, 2:ra36.
65. Scherz-Shouval R., Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007, 17:422-427.
66. Sies H. Strategies of antioxidant defense. Eur. J. Biochem. 1993, 215:213-219.
67. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
68. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
69. Tanner C.M., Ross G.W., Jewell S.A., Hauser R.A., Jankovic J., Factor S.A., Bressman S., Deligtisch A., Marras C., Lyons K.E., Bhudhikanok G.S., Roucoux D.F., Meng C., Abbott R.D., Langston J.W. Occupation and risk of parkinsonism: a multicenter case control study. Arch. Neurol. 2009, 66:1106-1113.
70. Thomas K.J., McCoy M.K., Blackinton J., Beilina A., van der Brug M., Sandebring A., Miller D., Maric D., Cedazo-Minguez A., Cookson M.R. DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum. Mol. Genet. 2011, 20:40-50.
71. Tong Y., Giaime E., Yamaguchi H., Ichimura T., Liu Y., Si H., Cai H., Bonventre J.V., Shen J. Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway. Mol. Neurodegener. 2012, 7:2.
72. van der Brug M.P., Blackinton J., Chandran J., Hao L.Y., Lal A., Mazan-Mamczarz K., Martindale J., Xie C., Ahmad R., Thomas K.J., Beilina A., Gibbs J.R., Ding J., Myers A.J., Zhan M., Cai H., Bonini N.M., Gorospe M., Cookson M.R. RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10244-10249.
73. Wang J.D., Huang C.C., Hwang Y.H., Chiang J.R., Lin J.M., Chen J.S. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br. J. Ind. Med. 1989, 46:856-859.
74. Wang L., Xie C., Greggio E., Parisiadou L., Shim H., Sun L., Chandran J., Lin X., Lai C., Yang W.J., Moore D.J., Dawson T.M., Dawson V.L., Chiosis G., Cookson M.R., Cai H. The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. J. Neurosci. 2008, 28:3384-3391.
75. Wang X., Moualla D., Wright J.A., Brown D.R. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity. J. Neurochem. 2010, 113:704-714.
76. Xu X.M., Lin H., Maple J., Björkblom B., Alves G., Larsen J.P., Møller S.G. The arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation. J. Cell Sci. 2010, 123:1644-1651.
77. Yamaguchi R., Perkins G. Dynamics of mitochondrial structure during apoptosis and the enigma of Opa1. Biochim. Biophys. Acta 2009, 1787:963-972.
78. Zarranz J.J., Alegre J., Gómez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atarés B., Llorens V., Gomez Tortosa E., del Ser T., Muñoz D.G., de Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 2004, 55:164-173.
79. Zhang L., Shimoji M., Thomas B., Moore D.J., Yu S.W., Marupudi N.I., Torp R., Torgner I.A., Ottersen O.P., Dawson T.M., Dawson V.L. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 2005, 14:2063-2073.
80. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Muller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.